How can non-clinical research inform the clinical development and prescribing of psychedelic drugs?
Professor David Heal of DevelRx will explore these issues at the Psychedelic Therapeutics and Drug Development Conference, 4th-6th May 2021.
This meeting to be held virtually will bring together the world’s leading scientists to discuss the challenges and opportunities in the research and development of psychedelics for various health conditions and the progress in regulatory approval for various psychedelics.